Literature DB >> 21922148

Expression and function of miR-27b in human glioma.

Lingchao Chen1, Huibing Li, Lei Han, Kailiang Zhang, Guangxiu Wang, Yongzhi Wang, Yanwei Liu, Yongri Zheng, Tao Jiang, Peiyu Pu, Chuanlu Jiang, Chunsheng Kang.   

Abstract

Our previous miRNAs profiling study showed that miR-27b was up-regulated in glioma cells compared with H4 low grade astrocytoma cells. However, the main function of miR-27b in glioma in not known yet. The aim of this study was to investigate the expression and function of miR-27b in the pathogenesis of glioma. Real-time PCR showed that miR-27b was up-regulated in glioma samples and glioma cells. Down-regulation of miR-27b triggered growth inhibition, induced apoptosis and inhibited invasion in glioma cells. Furthermore, TOPflash luciferase activity was decreased significantly, while FOPflash luciferase did not change significantly. In addition, Western blot assay showed that STAT3, c-myc and cyclin D1 were knocked down after treatment with miR-27b inhibitor. These findings suggest that aberrantly up-regulated miR-27b may be one of the critical factors that contribute to malignancy in human gliomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922148     DOI: 10.3892/or.2011.1458

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  30 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

Review 3.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

4.  MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.

Authors:  Hainan Li; Jenny Liu; Yihan Wang; Zhiyao Fu; Maik Hüttemann; Terrence J Monks; Alex F Chen; Jie-Mei Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-11       Impact factor: 4.310

5.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

6.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Authors:  Kun Wang; Xuan Wang; Jian Zou; Anling Zhang; Yingfeng Wan; Peiyu Pu; Zhengfei Song; Cong Qian; Yili Chen; Shuxu Yang; Yirong Wang
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

7.  Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.

Authors:  Jin-xing Wei; Li-hong Lv; Yun-le Wan; Yang Cao; Guo-lin Li; Hao-ming Lin; Rui Zhou; Chang-zhen Shang; Jun Cao; Hai He; Qing-fang Han; Pei-qing Liu; Gang Zhou; Jun Min
Journal:  Hepatology       Date:  2015-02-17       Impact factor: 17.425

Review 8.  A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion.

Authors:  Heidi G Møller; Andreas P Rasmussen; Hjalte H Andersen; Kasper B Johnsen; Michael Henriksen; Meg Duroux
Journal:  Mol Neurobiol       Date:  2012-10-02       Impact factor: 5.590

9.  The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.

Authors:  Reema A Ishteiwy; Toby M Ward; Derek M Dykxhoorn; Kerry L Burnstein
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Important miRs of pathways in different tumor types.

Authors:  Stefan Wuchty; Dolores Arjona; Peter O Bauer
Journal:  PLoS Comput Biol       Date:  2013-01-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.